1Mundy GR. Mechanisms of bone metastases. Cancer, 1997, 80:1546- 1556.
2Payne R. Mechanisms and management of bone pain. Cancer,1997, 80:160 - 161.
3Hayward MI, Howell DA, O'Donnell JF, et al. Hypercalcemia complicating small-cell carcinoma. Cancer, 1981, 48:1643 -1646.
4Michel F, Soler M, Imhof E, ctal, initial staging of non-small cell lung cancer: value of routine radioisotope hone scanning.Thorax, 1991, 46:469 - 473.
5Rosenthal DI. Radiologic diagnosis of bone metastases. Cancer,1997, 80:1595 -1607.
6Pfister DG, Johnson DH, Azzoli CG, et al. American society of clinical oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol, 2003, 22:330 -353.
7Bury T, Barroto A, Daenen F, et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nuel Med,1998, 25:1244 - 1247.
9Broos P, Reynders P, Van den Bogen W, et al. Surgical treatment of metastatic fracture of the femur improvement in quality of life.Acts Ortbop Belg, 1993, 59(Suppl):52 - 56.
10Patchell R, Tibbs PA, Regine WF, et al. A randomized trial of direct dcconlpressive surgical resection in the treatment of spinal cord compression caused by metastasis. J Clin Oncol, 2003, 21(23 Suppl) :237.
6Liu H,Zhan H,Sun D,et al.Analysis of multiple factors related to hematologic toxicity following 153Sm-EDTMP therapy[J].Cancer Biother Radiopharm,2007,22(4):515-520.
7Sartor O,Reid RH,Bushnell DL,et al.Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain[J].Cancer,2007,109(3):637-643.
